SpaceX Stock Is Down 30% From Its Post-IPO High. History Says This Will Happen Next.

SpaceX shares are down ~30% from the post-IPO peak of $202 to about $140, with the article citing a historical average 34% first-year IPO decline that could imply a drop to ~$89 by June 2027 (about 36% downside). It also flags major cash burn—free cash flow of -$25B in 1H 2026—suggesting the firm could run through its ~$100B cash and equivalents in ~2 years, potentially accelerating with AI capex. Offsetting this, revenue grew 92% to $7.8B in Q2 (AI sales more than tripled), and Wall Street’s median 12-month target of $217 implies ~55% upside from current levels.

Analysis

The near-term setup is more about supply than story. A sharp step-up in float into early December can overwhelm even strong fundamental narratives, especially in a name trading on scarcity and forward imagination rather than current cash generation. In that regime, the stock can underperform for 4-8 weeks even if the business remains strategically important, because incremental sellers set the clearing price.

The deeper issue is financing optionality: persistent negative free cash flow plus rising capex shifts the equity from a growth asset to a quasi-funding instrument. That usually compresses multiples once the market stops assuming every dollar of revenue growth is self-funding. If the next two prints show capex inflecting faster than gross profit, the market will start discounting dilution risk and lower terminal margins, not just slower growth.

Contrarian take: the consensus may be over-weighting the IPO analogue and under-weighting strategic demand for a category-defining asset. For a business with real network effects and a large addressable market, a 30% drawdown after debut can be digestion rather than a secular top, particularly if institutions want exposure but are waiting for float. The key falsifier is not the initial post-listing volatility; it is whether revenue growth re-accelerates while FCF burn narrows over the next 1-2 quarters. If that does not happen, the stock likely remains a multiple-compression candidate rather than a compounder.

Key Decisions for Investors

• Tactically short SPCX or buy 1-3 month put spreads into the lock-up window; best risk/reward is before the float increase is fully absorbed. Use a tight cover if the stock reclaims the post-IPO high-20s/low-30s percent drawdown band on volume.
• Pair trade: short SPCX vs long PLTR on a 1-3 month horizon to isolate the difference between a capital-intensive, cash-burning narrative and a profitable high-multiple narrative. The trade works if the market starts penalizing funding risk and rewards earnings quality.
• If options liquidity is thin, wait for the first post-lock-up dip to fade before fading rallies rather than initiating strength shorts immediately; the initial supply shock can overshoot intraday. Add only after a failed retest of the recent high.
• Set a hard alert on next-quarter FCF and capex commentary: if cash burn does not decelerate meaningfully, stay short; if management guides to materially lower burn and the stock holds above the post-IPO midrange, cover. The thesis is invalidated by improving self-funding metrics, not by sentiment alone.